Top

Gepubliceerd in:

30-10-2018 | BRIEF REPORT

Cognitive–affective depressive symptoms and substance use among Latino and non-Latino White patients in HIV care: an analysis of the CFAR network of integrated clinical systems cohort

Auteurs: John A. Sauceda, Nadra E. Lisha, Torsten B. Neilands, Katerina A. Christopoulos, W. Christopher Mathews, Julie H. Levison, Ann M. Dennis, Mallory O. Johnson

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 3/2019

Abstract

The disparity in viral suppression rates between Latino and non-Latino White patients in HIV care appears to be narrowing, but it is unclear if depression and substance use perpetuate this disparity. We analyzed electronic medical records from the CFAR network of integrated clinical systems cohort. First observations/enrollment data collected between 2007 and 2013 were analyzed, which included survey (race/ethnicity, depression, substance use, adherence) and clinical data (viral suppression). We estimated indirect effects with a regression-based bootstrapping method. In 3129 observations, Latinos and non-Latino Whites did not differ in depression or alcohol use (ORs 1.11, 0.99, ns), but did in drug use (OR 1.13, p < .001). For all patients, depression and substance use were indirectly associated with small increases (ORs 1.02–1.66) in the odds for a detectable viral load, via worse adherence. We conclude that variables not captured in EMR systems (e.g., health literacy, structural factors) may better explain viral suppression disparities that persist.

vorige artikel Understanding stress reports in daily life: a coordinated analysis of factors associated with the frequency of reporting stress

volgende artikel The influence of exercise training dose on fasting acylated ghrelin concentration in older women

Althoff, K. N., Buchacz, K., Hall, I., Zhang, J., Hanna, D. B., Rebeiro, P., et al. (2012). U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000–2008. Annals of Internal Medicine, 157, 325–335. https://doi.org/10.7326/0003-4819-157-5-201209040-00005 CrossRefPubMedPubMedCentral

Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet, 376, 367–387. https://doi.org/10.1016/s0140-6736(10)60829-X CrossRefPubMedPubMedCentral

Baum, M. K., Rafie, C., Lai, S., Sales, S., Page, J. B., & Campa, A. (2009). Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. Journal of Acquired Immune Deficiency Syndromes, 50, 93–99. https://doi.org/10.1097/QAI.0b013e3181900129 CrossRefPubMed

Baum, M. K., Rafie, C., Lai, S., Sales, S., Page, J. B., & Campa, A. (2010). Alcohol use accelerates HIV disease progression. AIDS Research and Human Retroviruses, 26, 511–518. https://doi.org/10.1089/aid.2009.0211 CrossRefPubMedPubMedCentral

Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., et al. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58, 721–728. https://doi.org/10.1001/archpsyc.58.8.721 CrossRefPubMed

Centers for Disease Control. (2017). More people with HIV have the virus under control [news release]. CDC NCHHSTP Newsroom: Atlanta, GA; July 27, 2017. https://www.cdc.gov/nchhstp/newsroom/2017/2017-HIV-Continuum-Press-Release.html. Accessed December 23, 2017.

Chaiyachati, K. H., Ogbuoji, O., Price, M., Suthar, A. B., Negussie, E. K., & Barnighausen, T. (2014). Interventions to improve adherence to antiretroviral therapy: A rapid systematic review. AIDS, 28, S187–S204. https://doi.org/10.1097/QAD.0000000000000252 CrossRefPubMed

Crepaz, N., Tang, T., Marks, G., & Hall, I. (2017). Viral suppression patterns among persons in the United States with diagnosed HIV infection in 2014. Annals of Internal Medicine, 167, 446–447. https://doi.org/10.7326/L17-0278 CrossRefPubMed

de Jonge, P., Ormel, J., van den Brink, R. H., van Melle, J. P., Spijkerman, T. A., Kuijper, A., et al. (2006). Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. American Journal of Psychiatry, 163, 138–144. https://doi.org/10.1176/appi.ajp.163.1.138 CrossRef

Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011). Depression and HIV/AIDS treatment non-adherence. A review and meta-analysis. Journal of Immune Deficiency Syndroms, 58, 181–187. https://doi.org/10.1097/QAI.0B013E31822D490A CrossRef

Gonzalez, J. S., Hendriksen, E. S., Collins, E. M., Durán, R. E., & Safren, S. A. (2009). Latinos and HIV/AIDS: Examining factors related to disparity and identifying opportunities for psychosocial intervention research. AIDS and Behavior, 13, 582–602. https://doi.org/10.1007/s10461-008-9402-4 CrossRefPubMed

Gonzalez, J. S., Kane, N. S., Binko, D. H., Shapira, A., & Hoogendoorn, C. J. (2016). Tangled up in Blue: Unraveling the links between emotional distress and treatment adherence in Type 2 diabetes. Diabetes Care. https://doi.org/10.2337/dc16-1657 CrossRefPubMedPubMedCentral

Hessol, N. A., Kalinowski, A., Benning, L., Mullen, J., Young, M., Palella, F., et al. (2007). Mortality among participants in the Multicenter AIDS Cohort Study and the Women’s Interagency HIV Study. Clinical Infectious Diseases, 44, 287–294. https://doi.org/10.1086/510488 CrossRefPubMed

Ironson, G., Fitch, C., & Stuetzle, R. (2017). Depression and survival in a 17-year longitudinal study of people with HIV: Moderating effects of race and education. Psychosomatic Medicine, 79, 749–756. https://doi.org/10.1097/PSY0000000000000488 CrossRefPubMedPubMedCentral

Kalichman, S. C., Rompa, D., & Cage, M. (2000). Distinguishing between overlapping somatic symptoms of depression and HIV disease progression in people living with HIV-AIDS. Journal of Nervous and Mental Disease, 188, 662–670.CrossRef

Kitahata, M. M., Rodriguez, B., Haubrich, R., Boswell, S., Mathews, W. C., Lederman, M. M., et al. (2008). Cohort profile: The centers for AIDS research network of integrated clinical systems. International Journal of Epidemiology, 37, 948–955. https://doi.org/10.1093/ije/dym231 CrossRefPubMedPubMedCentral

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9. Journal of General Internal Medicine, 16, 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x CrossRefPubMedPubMedCentral

Langebeek, N., Gisolf, E. H., Reiss, P., Vervoort, S. C., Hafsteinsdottir, T. B., Ricther, C., et al. (2014). Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: A meta-analysis. BMC Medicine, 12, 142. https://doi.org/10.1186/s12916-014-0142-1 CrossRefPubMedPubMedCentral

Leserman, J. (2008). Role of depression, stress, and trauma in HIV disease progression. Psychosomatic Medicine, 70, 539–545. https://doi.org/10.1097/PSY.0b013e3181777a5f CrossRefPubMed

Lu, M., Safren, S. A., Skolnik, P. R., Rogers, W. H., Coady, W., Hardy, H., et al. (2008). Optimal recall period and response task for self-reported HIV medication adherence. AIDS and Behavior, 12, 86–94. https://doi.org/10.1007/s10461-007-9261-4 CrossRefPubMed

Merlin, J. S., Cen, L., Praestgaard, A., Turner, M., Obando, A., Alpert, C., et al. (2012). Pain and physical and psychological symptoms in ambulatory HIV patients in the current treatment era. Journal of Pain and Symptom Management, 43, 638–645. https://doi.org/10.1016/j.jpainsymman.2011.04.019 CrossRefPubMed

Nachega, J. B., Uthman, O. A., del Rio, C., Mugavero, M. J., Rees, H., & Mills, E. J. (2014). Addressing the Achilles’ heel in the HIV Care Continuum for Success of a test-and-treat strategy to achieve an AIDS-Free Generation. Clinical Infectious Diseases, 59, S21–S27. https://doi.org/10.1093/cid/ciu299 CrossRefPubMedPubMedCentral

Page-Shafer, K., Delorenze, G. N., Satariano, W. A., & Winkelstein, W. (1996). Comorbidity and survival in HIV-infected men in the San Francisco Men’s Health Study. Annals of Epidemiology, 6, 420–430. https://doi.org/10.1016/S1047-2797(96)00064-6 CrossRefPubMed

Saberi, P., Comfort, M., Sheon, N., & Johnson, M. O. (2013). Qualitative study of the quality of sleep in marginalized individual living with HIV. Patient Preference and Adherence, 7, 499–507. https://doi.org/10.2147/ppa.s44595 CrossRefPubMedPubMedCentral

Safren, S. A., Bedoya, C. A., O’Cleirigh, C., Biello, K. B., Pinkston, M. M., Stein, M. D., et al. (2016). Cognitive-behavioural therapy for adherence and depression in patients with HIV: A three-arm randomised controlled trial. Lancet HIV, 3, e529–e538. https://doi.org/10.1016/s2352-3018(16)30053-4 CrossRefPubMedPubMedCentral

Safren, S. A., O’Cleirigh, C. M., Bullis, J. R., Otto, M. W., Stein, M. D., & Pollack, M. H. (2012). Cognitive-behavioral therapy for adherence and depression (CBT-AD) in HIV-infection injection drug users: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 80, 404–415. https://doi.org/10.1037/a0028208 CrossRefPubMedPubMedCentral

Sauceda, J. A., Brooks, R. A., Xavier, J., Maiorana, A., Georgetti Gomez, L., Zamudio-Haas, S., Rodriguez-Diaz, C. E., et al. (2018). From theory to application: A description of transnationalism in culturally-appropriate HIV interventions of outreach, access, and retention among Latino/a populations. Journal of Immigrant and Minority Health. https://doi.org/10.1007/s10903-018-0753-2

Sauceda, J. A., Johnson, M. O., & Saberi, P. (2016). Nonadherence as 4-day antiretroviral therapy interruptions: Do depression and race/ethnicity matter as much in the modern antiretroviral therapy era? AIDS and Behavior, 20, 2624–2628. https://doi.org/10.1007/s10461-015-1283-8 CrossRefPubMedPubMedCentral

Sauceda, J. A., Neilands, T. B., Johnson, M. O., & Saberi, P. (2017). An updated on the barriers to adherence and a definition of self-report non-adherence given advancements in antiretroviral therapy (ART). AIDS and Behavior, 22, 939–947. https://doi.org/10.1007/s10461-017-1759-9 CrossRef

Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R., & Grant, M. (1993). Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction, 88, 791–804. https://doi.org/10.1111/j.1360-0443 CrossRefPubMed

Sheehan, D. M., Trepka, M. J., & Dillon, F. R. (2015). Latinos in the United States on the HIV/AIDS care continuum by birth country/region: A systematic review of the literature. International Journal of STD and AIDS, 26, 1–12. https://doi.org/10.1177/0956462414532242 CrossRefPubMed

Simoni, J. M., Kurth, A. E., Pearson, C. R., Pantalone, D. W., Merrill, J. O., & Frick, P. A. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10, 227–245. https://doi.org/10.1007/s10461-006-9078-6 CrossRefPubMedPubMedCentral

Simoni, J. M., Wiebe, J. S., Sauceda, J. A., Huh, D., Sanchez, G., Longoria, V., et al. (2013). A preliminary RCT of CBT-AD for adherence and depression among HIV-positive Latinos on the U.S.-Mexico Border: The Nuevo Día Study. AIDS and Behavior, 17, 2816–2829. https://doi.org/10.1007/s10461-013-0538-5 CrossRefPubMedPubMedCentral

Uthman, O. A., Magidson, J. F., Safren, S. A., & Nachega, J. B. (2014). Depression and adherence to antiretroviral therapy in low-middle-and high-income countries: A systematic review and meta-anlysis. Current HIV/AIDS Reports, 3, 291–307. https://doi.org/10.1007/s11904-014-022-1 CrossRef

Wagner, G. J., Goggin, K., Remien, R. H., Rosen, M. I., Simoni, J. M., Bangsberg, D. R., et al. (2011). A closer look at depression and its relationship to HIV antiretroviral adherence. Annals of Behavioral Medicine, 42, 352–360. https://doi.org/10.1007/s12160-011-9295-8 CrossRefPubMed

WHO Assist Working Group. (2002). The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST): Development, reliability and feasibility. Addiction, 97, 1183–1194. https://doi.org/10.1046/j.1360-0443.2002.00185.x CrossRef

Zaller, N., Yang, C., Operario, D., Latkin, C., McKirnan, D., O’Donnell, L., et al. (2017). Alcohol and cocaine use among Latino and African American MSM in 6 US cities. Journal of Substance Abuse Treatment, 80, 26–32. https://doi.org/10.1016/j.jsat.2017.06.003 CrossRefPubMedPubMedCentral

Titel: Cognitive–affective depressive symptoms and substance use among Latino and non-Latino White patients in HIV care: an analysis of the CFAR network of integrated clinical systems cohort
Auteurs: John A. Sauceda
Nadra E. Lisha
Torsten B. Neilands
Katerina A. Christopoulos
W. Christopher Mathews
Julie H. Levison
Ann M. Dennis
Mallory O. Johnson
Publicatiedatum: 30-10-2018
Uitgeverij: Springer US
Gepubliceerd in: Journal of Behavioral Medicine / Uitgave 3/2019
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-018-9986-8

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 3/2019

Psychosocial factors associated with treatment outcomes in women with obesity and major depressive disorder who received behavioral activation for depression

Social support buffers the negative effects of stress in cardiac patients: a cross-sectional study with acute coronary syndrome patients

Perceived sensitivity to medicines, alcohol interactive toxicity beliefs, and medication adherence among people living with HIV who drink alcohol

The influence of exercise training dose on fasting acylated ghrelin concentration in older women

Physical activity, sitting, and risk factors of cardiovascular disease: a cross-sectional analysis of the CARRS study

Psychological threat avoidance as a barrier to HIV testing in gay/bisexual men